Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Affymax files for approval of kidney disease drug - Forbes |
 |
 |
|
Forbes It is intended to treat anemia in patients who have chronic kidney failure and are on dialysis. Affymax and Takeda previously called the drug candidate Hematide. Takeda, a Japanese drugmaker, has marketing rights outside the US Affymax, of Palo Alto, ... Affymax and Takeda Announce the Submission of a New Drug Application for |
